American International Group, Inc. Anavex Life Sciences Corp. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.55 - $6.75 $1,387 - $2,058	-305 Reduced 0.85%	35,624 $181,000
Q4 2023 Feb 13, 2024	BUY	$5.04 - $9.95 $1,733 - $3,422	344 Added 0.97%	35,929 $334,000
Q3 2023 Nov 13, 2023	BUY	$6.55 - $9.37 $11,704 - $16,744	1,787 Added 5.29%	35,585 $233,000
Q2 2023 Aug 04, 2023	BUY	$7.66 - $9.5 $3,240 - $4,018	423 Added 1.27%	33,798 $274,000
Q1 2023 May 12, 2023	BUY	$8.32 - $11.75 $5,524 - $7,802	664 Added 2.03%	33,375 $286,000
Q4 2022 Feb 10, 2023	SELL	$7.65 - $14.43 $902 - $1,702	-118 Reduced 0.36%	32,711 $302,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $7,912 - $11,432	889 Added 2.78%	32,829 $339,000
Q2 2022 Aug 12, 2022	SELL	$7.31 - $12.84 $10,000 - $17,565	-1,368 Reduced 4.11%	31,940 $320,000
Q1 2022 May 13, 2022	SELL	$9.74 - $17.69 $22,830 - $41,465	-2,344 Reduced 6.57%	33,308 $410,000
Q4 2021 Feb 11, 2022	BUY	$16.88 - $23.31 $8,980 - $12,400	532 Added 1.51%	35,652 $618,000
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $5,836 - $8,935	347 Added 1.0%	35,120 $630,000
Q2 2021 Aug 13, 2021	BUY	$10.16 - $28.86 $7,498 - $21,298	738 Added 2.17%	34,773 $795,000
Q1 2021 May 07, 2021	BUY	$5.17 - $16.13 $18,213 - $56,825	3,523 Added 11.55%	34,035 $509,000
Q4 2020 Feb 12, 2021	SELL	$4.01 - $7.58 $3,508 - $6,632	-875 Reduced 2.79%	30,512 $165,000
Q3 2020 Nov 04, 2020	BUY	$3.8 - $5.0 $383 - $505	101 Added 0.32%	31,387 $143,000
Q2 2020 Aug 12, 2020	BUY	$2.62 - $5.2 $5,528 - $10,972	2,110 Added 7.23%	31,286 $154,000
Q1 2020 May 04, 2020	BUY	$2.38 - $5.81 $5,462 - $13,333	2,295 Added 8.54%	29,176 $92,000
Q4 2019 Feb 05, 2020	SELL	$2.31 - $3.14 $522 - $709	-226 Reduced 0.83%	26,881 $70,000
Q3 2019 Nov 08, 2019	SELL	$2.22 - $3.9 $419 - $737	-189 Reduced 0.69%	27,107 $86,000
Q2 2019 Aug 13, 2019	BUY	$2.75 - $3.7 $75,064 - $100,995	27,296 New	27,296 $92,000
Q2 2018 Aug 08, 2018	SELL	$2.08 - $4.26 $52,436 - $107,394	-25,210 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$2.32 - $3.44 $174 - $258	75 Added 0.3%	25,210 $70,000
Q4 2017 Feb 09, 2018	BUY	$3.12 - $4.94 $1,847 - $2,924	592 Added 2.41%	25,135 $81,000
Q3 2017 Nov 09, 2017	BUY	$3.42 - $4.87 $83,937 - $119,524	24,543	24,543 $102,000

Others Institutions Holding AVXL

# of Institutions

152

Shares Held

26.5M

Call Options Held

674K

Put Options Held

811K

Black Rock Inc. New York, NY

6.39M
Shares

$36.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.55M
Shares

$25.8 Million
0.0% of portfolio
State Street Corp Boston, MA

3.74M
Shares

$21.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.83M
Shares

$10.4 Million
0.0% of portfolio
Two Sigma Investments, LP New York, NY

1.01M
Shares

$5.75 Million
0.01% of portfolio

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account